This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Oklahoma. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Innovations of Carey N Pope in Cardiac Treatment
Introduction
Carey N Pope is a notable inventor based in Stillwater, OK (US), recognized for his contributions to medical technology. His innovative work focuses on the treatment of cardiac disorders, particularly through the use of advanced methods for targeted delivery of therapeutic agents.
Latest Patents
Pope holds a patent for a method titled "Magnetically-targeted treatment for cardiac disorders." This patent describes a technique for the targeted delivery of neurotoxins, neurosuppressants, or other compounds that have a neurologic effect to specific locations within the heart. The method aims to address issues related to the cardiac autonomic nervous system, specifically targeting nodes such as the atrial ganglionated plexi (GP). The use of magnetically-susceptible nanoparticles allows for effective suppression of GP activity and atrial fibrillation without causing permanent damage to the myocardium or intrinsic cardiac autonomic nervous system. He has 1 patent to his name.
Career Highlights
Pope's career is marked by his dedication to advancing cardiac treatment methodologies. His innovative approach has the potential to significantly improve patient outcomes in the management of atrial fibrillation and related cardiac disorders.
Collaborations
Throughout his career, Pope has collaborated with esteemed colleagues, including Kenneth J Dormer and Sunny Po, who contribute to the research and development of his innovative techniques.
Conclusion
Carey N Pope's work exemplifies the intersection of innovation and medical science, particularly in the realm of cardiac treatment. His patented methods represent a significant advancement in targeted therapies, showcasing the potential for improved patient care in cardiology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
